Yuhui Zhang, Marianna Adamo, Changhong Zou, Aldostefano Porcari, Daniela Tomasoni, Maddalena Rossi, Marco Merlo, Huihui Liu, Jinxi Wang, Ping Zhou, Marco Metra, Gianfranco Sinagra, Jian Zhang
Hypertrophic cardiomyopathy is an important cause of heart failure and arrhythmias, including sudden death, with a major impact on the healthcare system. Genetic causes and different phenotypes are now increasingly being identified for this condition. In addition, specific medications, such as myosin inhibitors, have been recently shown as potentially able to modify its symptoms, hemodynamic abnormalities and clinical course. Our article aims to provide a comprehensive outline of the epidemiology, diagnosis and treatment of hypertrophic cardiomyopathy in the current era...
April 17, 2024: Journal of Cardiovascular Medicine